Cytokinetics Common Stock Shares Outstanding from 2010 to 2024
| CYTK Stock | USD 48.41 1.46 2.93% |
Common Stock Shares Outstanding | First Reported 2003-03-31 | Previous Quarter 99.1 M | Current Value 101.9 M | Quarterly Volatility 30.3 M |
Check Cytokinetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cytokinetics' main balance sheet or income statement drivers, such as Interest Expense of 60.6 M, Other Operating Expenses of 528.9 M or Research Development of 334.1 M, as well as many indicators such as Price To Sales Ratio of 1.1 K, Dividend Yield of 0.0 or Days Sales Outstanding of 59.08. Cytokinetics financial statements analysis is a perfect complement when working with Cytokinetics Valuation or Volatility modules.
Cytokinetics | Common Stock Shares Outstanding |
Latest Cytokinetics' Common Stock Shares Outstanding Growth Pattern
Below is the plot of the Common Stock Shares Outstanding of Cytokinetics over the last few years. It is the total number of shares of a company's common stock that are currently owned by all its shareholders. Cytokinetics' Common Stock Shares Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cytokinetics' overall financial position and show how it may be relating to other accounts over time.
| Common Stock Shares Outstanding | 10 Years Trend |
|
Common Stock Shares Outstanding |
| Timeline |
Cytokinetics Common Stock Shares Outstanding Regression Statistics
| Arithmetic Mean | 50,995,671 | |
| Geometric Mean | 31,973,912 | |
| Coefficient Of Variation | 60.32 | |
| Mean Deviation | 24,551,267 | |
| Median | 49,404,000 | |
| Standard Deviation | 30,758,307 | |
| Sample Variance | 946.1T | |
| Range | 101.2M | |
| R-Value | 0.99 | |
| Mean Square Error | 17.1T | |
| R-Squared | 0.98 | |
| Slope | 6,819,748 | |
| Total Sum of Squares | 13245T |
Cytokinetics Common Stock Shares Outstanding History
About Cytokinetics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Cytokinetics income statement, its balance sheet, and the statement of cash flows. Cytokinetics investors use historical funamental indicators, such as Cytokinetics's Common Stock Shares Outstanding, to determine how well the company is positioned to perform in the future. Although Cytokinetics investors may use each financial statement separately, they are all related. The changes in Cytokinetics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Cytokinetics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Cytokinetics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Cytokinetics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 96.5 M | 101.4 M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Cytokinetics using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Additional Information and Resources on Investing in Cytokinetics Stock
When determining whether Cytokinetics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Cytokinetics Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Cytokinetics Stock. Highlighted below are key reports to facilitate an investment decision about Cytokinetics Stock:Check out the analysis of Cytokinetics Correlation against competitors. For more information on how to buy Cytokinetics Stock please use our How to buy in Cytokinetics Stock guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. If investors know Cytokinetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytokinetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.40) | Revenue Per Share 0.038 | Quarterly Revenue Growth (0.82) | Return On Assets (0.37) | Return On Equity (5.72) |
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytokinetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytokinetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytokinetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.